本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Summit Therapeutics PLC

26.20
-1.4300-5.18%
盤前26.380.1800+0.69%07:07 EDT
成交量:301.07萬
成交額:8,050.20萬
市值:194.58億
市盈率:-77.16
高:28.13
開:27.91
低:26.05
收:27.63
資料載入中...
2020/02/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/23

超過5%披露

General statement of acquisition of beneficial ownership
2020/01/16

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/27

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/17

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/10

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/06

非美公司披露報告

[Amend] Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/18

SEC問詢函

[Cover]Correspondence
2019/06/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]